Hitachi, Sophia Genetics partner on genomics
Hitachi and Sophia Genetics are joining forces to bring clinical, genomic, and real-world insights to healthcare providers as well as pharmaceutical and biopharmaceutical companies. Read More
Chime secures $190M to expand biopharma manufacturing
China-based contract development and manufacturing organization Chime Biologics has secured $190 million to finance the second phase of its biomanufacturing facility in Wuhan. Read More
Brooklyn ImmunoTherapeutics, NTN complete reverse merger
Brooklyn ImmunoTherapeutics has completed its reverse merger with NTN Buzztime and will trade under the new ticker "BTX." The company will focus on advancement of its lead cytokine-based therapy, IRX-2. Read More
Sexton collaborates to improve flexible automation
Sexton Biotechnologies has formed a partnership with Hitech Health and Med Institute covering flexible automation for cell and gene therapy manufacturers. Read More
Twist, Kyowa Kirin partner on antibody discovery
Twist Bioscience has inked a deal with pharmaceutical company Kyowa Kirin Pharmaceutical Research to develop novel antibodies for therapeutic use against an undisclosed G protein-coupled receptor target molecule. Read More
Broad Institute launches new center with $150M endowment
The Broad Institute of the Massachusetts Institute of Technology and Harvard University have announced the launch of a new research center intended to catalyze a new scientific discipline at the intersection of biology and machine learning. Read More
CyanVac taps Exothera to produce COVID-19 vaccine for trials
CyanVac has selected contract development and manufacturing organization Exothera for the development and manufacturing of its COVID-19 intranasal vaccine, which is based on a proprietary parainfluenza virus 5 vector. Read More
New report investigates availability of orphan drugs
Findings of a new study commissioned by the National Organization for Rare Disorders explores the effect of patents and exclusivity on orphan drug products. Read More
Lassen, Cedars Sinai team up to study mAbs for treating lung fibrosis
Lassen Therapeutics is collaborating with Cedars Sinai Medical Center to study the role of interleukin 11 signaling and its inhibition in lung fibrosis, along with the potential therapeutic effect of monoclonal antibodies (mAbs) to block IL-11 signaling in preclinical models. Read More
New paper identifies how PVSRIPO stimulates antitumor immunity
A new study published in Nature Communications found that intratumoral PVSRIPO therapy through unique activation of antigen-presenting cells in the tumor microenvironment stimulates functional CD8+ T-cell responses, leading to systemic antitumor immunity. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
